LIVANOVA USA, INC.

Lobbying for LIVANOVA USA, INC.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Texas · House · Senate · $140,000.00 expenses · posted Oct 20, 2025

Lobbying activity 2

Medicare/Medicaid

Issues related to Medicare beneficiary access to treatments for depression and epilepsy. Issues related to Medicare beneficiary access to procedures performed in ambulatory surgical centers.

Health Issues

Issues related to epilepsy. Issues related to telehealth.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.